TP53 and breast carcinoma: To study the kinetics of UBE4B, Hdm2, Pirh2, Cop1 and CHIP induction in response to p53 activation, MCF7 cells (a breast cancer cell line) harboring wild-type p53 were treated with IR (6 Gy) for the indicated periods of time.